Editorial Perspectives On Patient Recruitment

51. BMS Uses Virtual Technology To Empower Patient Communities 7/28/2020

    Patient centricity continues to play a pivotal role in how healthcare companies design and build clinical trials. The drive to get the patient voice involved in trial design has resulted in more companies interacting with patients and patient advocacy groups.

52. ADAPTABLE Study Shows The Potential Of Virtual Trials 7/21/2020

    DCRI and PCORI started the ADAPTABLE clinical trial to the effect of different aspirin doses on patients with heart disease. Now that the trial is winding down, it's success has also shown sponsor companies how to successfully navigate a large, virtual clinical trial.

53. Janssen Study Shows How To Create Patient Diversity In Trials 5/21/2020

    Patient diversity is a problem that exists in clinical trials. Participants across all therapeutic areas have tended to be Caucasian and male. With the FDA now pressuring pharma companies to run trials with patients who better resemble the overall population, a scramble is on to make trials more diverse. 

54. Regeneron's COVID-19 Trial Reaches Patients In 5 Days 5/12/2020

    AdventHealth’s most serious COVID-19 patients were in the ICU and needed immediate help. When it learned about a clinical trial being conducted by Regeneron Pharmaceuticals, it acted quickly. “We were able to get this trial up and running in a record period of time,” states Dr. Steven Smith. “We signed the documents with Regeneron and were administering the drug to our patients in less than five days.” 

55. The (Almost) Insurmountable Recruitment Challenges Of Antibiotic Clinical Trials 5/7/2020

    Clinical trials are difficult. Every clinical executive I interview can rattle off a list of challenges they face and how they are attempting to overcome them. Still, anyone who thinks they have it tough conducting trials should pause and have a moment of reflection for those companies fighting to stay afloat in the challenging area of antibiotics. 

56. Despite COVID-19, Patients Are Interested In New Trials 4/14/2020

    Patient-recruitment company SubjectWell connected with sites and patients to learn how the uncertainty of the COVID-19 pandemic is impacting sites and the feelings of patients regarding their participation in clinical trials.

57. AdventHealth Recruits 10,000 Patients For WholeMe DNA Clinical Trial 3/23/2020

    In late 2018, AdventHealth funded and developed a new center for genomic health and personalized medicine. The first genomics project AdventHealth decided to undertake is WholeMe, a clinical trial that will sequence the DNA of 10,000 Floridians.

58. Belong.Life Creates World's Largest Cancer Social Network 3/5/2020

    The lack of an information source for cancer patients prompted Irad Deutsch to found Belong.Life alongside CEO Eliran Malki. Today Deutsch is CTO of the organization, which is billed as the world’s largest cancer social network.

59. Overcome The 6 Main Aversions To Clinical Trial Participation 2/20/2020

    Recruitment is a problem for most clinical trials, and there are many reasons patients are not more willing to participate. Many are not aware of trials, they have physicians who do not refer them, or they do not understand the need for trials.

60. A Small Biotech's 3 Steps To Recruitment Success 2/18/2020

    Millendo Therapeutics has a pipeline of products addressing endocrine diseases. One of the company's trials, ZEPHYR, enrolled over 150 patients at 38 sites worldwide. Recruitment was nothing short of a success story. Millendo began recruiting patients for that study well after its main competitors yet was the first to meet its enrollment target.